CDC42 and colorectal cancer: The pro-oncogenic role of CDC42 in this tumor type has been further demonstrated in several independent studies, in which the overexpression or silencing of CDC42 either in vitro or in vivo showed oncogenic-phenotypic effects in different colorectal cancer cell lines and mouse models [10–12].